Patient Preferences for the Chemoprevention of Esophageal Adenocarcinoma in Barrett’s Esophagus

OBJECTIVES: Although evidence suggests that aspirin and celecoxib may reduce the risk of esophageal adenocarcinoma (EAC) in patients with Barrett’s esophagus (BE), these drugs can also cause harmful side effects. Our aim was to determine and characterize preferences for these two drugs in patients w...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Hur, Chin, Broughton, Darcy E., Ozanne, Elissa, Yachimski, Patrick, Nishioka, Norman S., Gazelle, G. Scott
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: 2008
Pynciau:
Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC3736801/
https://ncbi.nlm.nih.gov/pubmed/18775019
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1572-0241.2008.02117.x
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg